Table 1.
Clinical characteristic of the patients with inflammatory bowel disease
| UC | CD | |
| Patients no | 53 | 52 |
| Mean age ± SD (range), years | 49.8 ± 13.9 (20–79) | 36.6 ± 13.6 (17–69) |
| Mean duration of disease ± SD (range), months | 85.9 ± 81.8 (1–348) | 72.4 ± 68.6 (1–388) |
| Male | 30 | 21 |
| Female | 23 | 31 |
| Current smokers | 5 | 32 |
| Ex smokers | 20 | 2 |
| Never smokers | 28 | 18 |
| Disease extent (UC) | ||
| Proctitis | 10 | |
| Left-sided colitis | 15 | |
| Extensive colitis | 28 | |
| Disease location (CD) | ||
| Ileum | 17 | |
| Colon | 4 | |
| Ileum + colon | 31 | |
| Disease behavior (CD) | ||
| Inflammatory | 32 | |
| Strictrurizing | 8 | |
| Penetrating | 12 | |
| Active disease | 22 | 17 |
| Inactive disease | 31 | 35 |
| Extraintestinal manifestations | 24 | 29 |
| Current treatment* | ||
| 5-ASA | 51 | 51 |
| Steroids | 28 | 43 |
| Enemas (5-ASA and/or steroids) | 27 | 5 |
| Immunosuppressive agents | 13 | 21 |
| Metronidazole | 11 | 28 |
| Infliximab | 4 | 15 |
| Parenteral nutrition | 2 | 1 |
*Some patients received > 1 drug.